C57BL/6J (B6) mice are susceptible to high-fat diet (HFD)-induced obesity and have been used in metabolism research for many decades. However, the genetic component of HFD-induced obesity has not yet been elucidated. This study reports evidence for a paternal transmission of HFD-induced obesity and a correlated expression of Igf2 and Peg3 (paternal expressed gene 3) imprinted genes. We found that PWK mice are resistant to HFD-induced obesity compared to C57BL/6J mice. Therefore, we generated and analyzed reciprocal crosses between these mice, namely; (PWK×B6) F1 progeny with B6 father and (B6×PWK) F1 progeny with PWK father. The (PWK×B6) F1 mice were more sensitive to diet-induced obesity compared to (B6×PWK) F1 mice, suggesting a paternal transmission of diet-induced obesity. Expression analysis of imprinted genes in adipocytes revealed that HFD influences the expression of some of the imprinted genes in adipose tissue in B6 and PWK mice. Interestingly, Igf2 and Peg3, which are paternally expressed imprinted genes involved in the regulation of body fat accumulation, were down-regulated in B6 and (PWK×B6) F1 mice, which are susceptible to HFD-induced obesity, but not in PWK and (B6×PWK) F1 mice, which are resistant. Furthermore, in vitro analysis showed that Igf2, but not Peg3, had an anti-inflammatory effect on TNF-α induced MCP-1 expression in adipocytes. Taken together, our findings suggest that the down-regulation of Igf2 and Peg3 imprinted genes in adipocytes may be involved in the paternal transmission of HFD-induced obesity.
References
[1]
Nicholls RD, Knepper JL (2001) Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genomics Hum Genet 2: 153–175.
[2]
Takahashi M, Kamei Y, Ezaki O (2005) Mest/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size. Am J Physiol Endocrinol Metab 28: E117–E124.
[3]
Koza RA, Nikonova L, Hogan J, Rim JS, Mendoza T, et al. (2006) Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet 2: e81.
[4]
Smas CM, Sul HS (1996) Characterization of Pref-1 and its inhibitory role in adipocyte differentiation. Int J Obes Relat Metab Disord 20 (Suppl 3)S65–72.
[5]
Moon YS, Smas CM, Lee K, Villena JA, Kim KH, et al. (2002) Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol 22: 5585–5592.
[6]
Lee K, Villena JA, Moon YS, Kim KH, Lee S, et al. (2003) Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest111: 453–461.
[7]
Curley JP, Pinnock SB, Dickson SL, Thresher R, Miyoshi N, et al. (2005) Increased body fat in mice with a targeted mutation of paternally expressed imprinted gene Peg3. FASEB J 19: 1302–1304.
[8]
LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, et al. (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11: 847–862.
[9]
Surwit RS, Kuhn CM, Cochrane C, Mccubbin JA, Feinglos MN (1988) Diet-induced Type II diabetes in C57BL/6J mice. Diabetes 37: 1163–1167.
[10]
Alexander J, Chang GQ, Dourmashkin JT, Leibowitz SF (2006) Distinct phenotypes of obesity-prone AKR/J, DBA2J and C57BL/6J mice compared to control strains. Int J Obes (Lond). 30: 50–59.
[11]
Lucifero D, Mertineit C, Clarke HJ, Bestor TH, Trasler JM (2002) Methylaion dynamics of imprinted genes in mouse germ cells. Genomics. 79: 530–538.
[12]
Feil R, Walter J, Allen ND, Reik W (1994) Developmental control of allelic methylation in the imprinted mouse Igf2 and H19 genes. Development 120: 2933–2943.
[13]
Tremblay KD, Duran KL, Bartolomei MS (1997) A 5' 2-kilobase-pair region of the imprinted mouse H19 gene exhibits exclusive paternal methylation throughout development. Mol Cell Biol. 17: 4322–4329.
[14]
Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, et al. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 46: 2347–55.
[15]
Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest. 116: 1793–801.
[16]
De Taeye BM, Novitskaya T, McGuinness OP, Gleaves L, Medda M, et al. (2007) Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am J Physiol Endocrinol Metab. 293: E713–725.
[17]
Sartipy P, Loskutoff DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A. 100: 7265–7270.
[18]
Díez JJ, Iglesias P (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 148: 293–300.
[19]
Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, et al. (1994) Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem. 269: 13779–84.
[20]
Rossetti L, Barzilai N, Chen W, Harris T, Yang D, et al. (1996) Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice. J Biol Chem. 271: 203–8.
[21]
de Koning DJ, Rattink AP, Harlizius B, van Arendonk JA, Brascamp EW, et al. (2002) Genome-wide scan for body composition in pigs reveals important role of imprinting. Proc Natl Acad Sci U S A. 97: 7947–7950.
[22]
DeChiara TM, Efstratiadis A, Robertson EJ (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 345: 78–80.
[23]
Jones BK, Levorse J, Tilghman SM (2001) Deletion of a nuclease-sensitive region between the Igf2 and H19 genes leads to Igf2 misregulation and increased adiposity. Hum Mol Genet. 10: 807–814.
[24]
Sandhu MS, Gibson JM, Heald AH, Dunger DB, Wareham NJ (2003) Low circulating IGF-II concentrations predict weight gain and obesity in humans. Diabetes. 52: 1403–1408.
[25]
O'Dell SD, Bujac SR, Miller GJ, Day IN (1999) Associations of IGF2 ApaI RFLP and INS VNTR class I allele size with obesity. Eur J Hum Genet. 7: 821–827.
[26]
Gaunt TR, Cooper JA, Miller GJ, Day IN, O'Dell SD (2001) Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet. 10: 1491–1501.
[27]
Ravussin E (2002) Adiponectin enhances insulin action by decreasing ectopic fat deposition. Pharmacogenomics J. 2: 4–7.
[28]
Matsuzawa Y (2010) Adiponectin: a key player in obesity related disorders. Curr Pharm Des. 16: 1896–901.
[29]
Toye AA, Lippiat JD, Proks P, Shimomura K, Bentley L, et al. (2005) A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia. 48: 675–86.
[30]
Andrikopoulos S, Massa CM, Aston-Mourney K, Funkat A, Fam BC, et al. (2005) Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet. J Endocrinol. 187: 45–53.
[31]
Kooptiwut S, Zraika S, Thorburn AW, Dunlop ME, Darwiche R, et al. (2002) Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure. Endocrinology. 143: 2085–92.
[32]
Ahrén B, Pacini G (2002) Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice. Am J Physiol Endocrinol Metab. 283: E738–44.
[33]
Piya MK, McTernan PG, Kumar S (2013) Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin. J Endocrinol. 216: T1–T15.
[34]
Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 7: 947–53.
[35]
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 7: 941–946.
[36]
Varrault A, Gueydan C, Delalbre A, Bellmann A, Houssami S, et al. (2006) Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. Dev Cell. 11: 711–22.
[37]
Holt LJ, Siddle K (2005) Grb10 and Grb14: enigmatic regulators of insulin action-and more? Biochem J. 388(Pt 2): 393–406.
[38]
Smith FM, Holt LJ, Garfield AS, Charalambous M, Koumanov F, et al. (2007) Mice with a disruption of the imprinted Grb10 gene exhibit altered body composition, glucose homeostasis, and insulin signaling during postnatal life. Mol Cell Biol. 27: 5871–86.
